VITESSE DEVELOPMENTS LIMITED

Company number 03210121 ·

Active - Proposal to Strike off

Net assets, total assets & total liabilities 2017 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£100k -£50k £0 £50k £100k £150k £200k 2017 2018 2019 2019 2020 2021 2022 2023 2024 2025 Total assets 2017: £93,042 Total assets 2018: £113,976 Total assets 2019: £117,261 Total assets 2019: £117,261 Total assets 2020: £129,274 Total assets 2021: £141,391 Total assets 2022: £156,053 Total assets 2023: £183,372 Total assets 2024: £176,413 Total assets 2025: £47,605 Total assets Net assets 2017: £17,809 Net assets 2018: £32,741 Net assets 2019: £39,748 Net assets 2019: £39,748 Net assets 2020: £49,523 Net assets 2021: £109,277 Net assets 2022: £108,276 Net assets 2023: £98,496 Net assets 2024: £78,080 Net assets 2025: £2,936 Net assets Total liabilities 2017: -£75,233 Total liabilities 2018: -£81,235 Total liabilities 2019: -£77,513 Total liabilities 2019: -£77,513 Total liabilities 2020: -£79,751 Total liabilities 2021: -£32,114 Total liabilities 2022: -£47,777 Total liabilities 2023: -£84,876 Total liabilities 2024: -£98,333 Total liabilities 2025: -£44,669 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Balance sheet by year 15 years

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-04-30 £47,605 -£44,669 £2,936
2024-03-31 £176,413 -£98,333 £78,080
2023-03-31 £183,372 -£84,876 £98,496
2022-03-31 £156,053 -£47,777 £108,276
2021-03-31 £141,391 -£32,114 £109,277
2020-03-31 £129,274 -£79,751 £49,523
2019-03-31 £117,261 -£77,513 £39,748
2019-03-30 £117,261 -£77,513 £39,748
2018-03-31 £113,976 -£81,235 £32,741
2017-03-31 £93,042 -£75,233 £17,809
2016-03-31 £69,381 -£65,546 £3,835
2015-03-31 £86,153 -£85,447 £706
2014-03-31 £83,773 -£82,256 £1,517
2013-03-31 £62,958 -£62,709 £249
2012-03-31 £48,975 -£48,590 £385 £37,938

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.